Abstract This 2022 European Atherosclerosis Society lipoprotein (a)[Lp (a)] consensus
statement updates evidence for the role of Lp (a) in atherosclerotic cardiovascular disease …

Abstract Interleukin-6 (IL-6) is a pivotal cytokine with a diverse repertoire of physiological
functions that include regulation of immune cell proliferation and differentiation …

Background IL-6 has emerged as a pivotal factor in atherothrombosis. Yet, the safety and
efficacy of IL-6 inhibition among individuals at high atherosclerotic risk but without a …

Abstract Aims Lipoprotein (a)[Lp (a)] is elevated in 20–30% of people. This study aimed to
assess the effect of statins on Lp (a) levels. Methods and results This subject-level meta …

Mortality among patients with chronic kidney disease (CKD) is largely a consequence of
cardiovascular disease (CVD) and is a particular concern given the increasing prevalence of …

Obesity and type 2 diabetes (T2D) are metabolic disorders that are linked to microbiome
alterations. However, their co-occurrence poses challenges in disentangling microbial …

Lipoprotein (a)[Lp (a)] has attracted the interest of researchers and physicians due to its
intriguing properties, including an intragenic multiallelic copy number variation in the LPA …

Human gut microbiota is an important determinant for health and disease, and recent
studies emphasize the numerous factors sha** its diversity. Here we performed a genome …

Epidemiological and clinical studies over the past decade have firmly established that
elevated plasma concentrations of lipoprotein (a)(Lp (a)) are an important, independent and …

Metformin is the first-line therapy for treating type 2 diabetes and a promising anti-aging
drug. We set out to address the fundamental question of how gut microbes and nutrition, key …